- Home
- LNTH vs OTEX Comparison
LNTH vs OTEX Comparison
Compare LNTH & OTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- OTEX
- Stock Information
- Founded
- LNTH 1956
- OTEX 1991
- Country
- LNTH United States
- OTEX Canada
- Employees
- LNTH N/A
- OTEX N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OTEX EDP Services
- Sector
- LNTH Health Care
- OTEX Technology
- Exchange
- LNTH Nasdaq
- OTEX Nasdaq
- Market Cap
- LNTH 7.5B
- OTEX N/A
- IPO Year
- LNTH 2015
- OTEX 1998
- Fundamental
- Price
- LNTH $96.16
- OTEX $25.29
- Analyst Decision
- LNTH Strong Buy
- OTEX Hold
- Analyst Count
- LNTH 6
- OTEX 8
- Target Price
- LNTH $129.83
- OTEX $32.71
- AVG Volume (30 Days)
- LNTH 864.1K
- OTEX 1.7M
- Earning Date
- LNTH 05-01-2025
- OTEX 05-01-2025
- Dividend Yield
- LNTH N/A
- OTEX 4.14%
- EPS Growth
- LNTH N/A
- OTEX 421.00
- EPS
- LNTH 4.36
- OTEX 2.45
- Revenue
- LNTH $1,533,910,000.00
- OTEX $5,412,785,000.00
- Revenue This Year
- LNTH $6.59
- OTEX N/A
- Revenue Next Year
- LNTH $11.80
- OTEX $2.07
- P/E Ratio
- LNTH $22.06
- OTEX $10.35
- Revenue Growth
- LNTH 18.32
- OTEX N/A
- 52 Week Low
- LNTH $58.16
- OTEX $24.86
- 52 Week High
- LNTH $126.89
- OTEX $39.00
- Technical
- Relative Strength Index (RSI)
- LNTH 48.12
- OTEX 37.20
- Support Level
- LNTH $94.80
- OTEX $25.90
- Resistance Level
- LNTH $100.73
- OTEX $27.36
- Average True Range (ATR)
- LNTH 3.97
- OTEX 0.57
- MACD
- LNTH -0.97
- OTEX 0.09
- Stochastic Oscillator
- LNTH 8.41
- OTEX 17.20
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.